[1] Russell FA,King R,Smillie SJ,Kodji X,Brain SD, Calcitonin gene-related peptide: physiology and pathophysiology. Physiological reviews. 2014 Oct;     [PubMed PMID: 25287861]
[2] Stoker K,Baker DE, Erenumab-aooe. Hospital pharmacy. 2018 Dec;     [PubMed PMID: 30559520]
[3] MacGregor EA, Migraine. Annals of internal medicine. 2017 Apr 4;     [PubMed PMID: 28384749]
[4] Roy A,Adinoff B,DeJong J,Linnoila M, Cerebrospinal fluid variables among alcoholics lack seasonal variation. Acta psychiatrica Scandinavica. 1991 Dec;     [PubMed PMID: 1724338]
[5] Kee Z,Kodji X,Brain SD, The Role of Calcitonin Gene Related Peptide (CGRP) in Neurogenic Vasodilation and Its Cardioprotective Effects. Frontiers in physiology. 2018;     [PubMed PMID: 30283343]
[6] McLatchie LM,Fraser NJ,Main MJ,Wise A,Brown J,Thompson N,Solari R,Lee MG,Foord SM, RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 1998 May 28;     [PubMed PMID: 9620797]
[7] Negro A,Lionetto L,Simmaco M,Martelletti P, CGRP receptor antagonists: an expanding drug class for acute migraine? Expert opinion on investigational drugs. 2012 Jun;     [PubMed PMID: 22512641]
[8] Foord SM,Marshall FH, RAMPs: accessory proteins for seven transmembrane domain receptors. Trends in pharmacological sciences. 1999 May;     [PubMed PMID: 10354609]
[9] Dhillon S, Eptinezumab: First Approval. Drugs. 2020 May;     [PubMed PMID: 32266704]
[10] Lamb YN, Galcanezumab: First Global Approval. Drugs. 2018 Nov;     [PubMed PMID: 30378008]
[11] Hoy SM, Fremanezumab: First Global Approval. Drugs. 2018 Nov;     [PubMed PMID: 30406901]
[12] Negro A,Martelletti P, Gepants for the treatment of migraine. Expert opinion on investigational drugs. 2019 Jun;     [PubMed PMID: 31081399]
[13] Markham A, Erenumab: First Global Approval. Drugs. 2018 Jul;     [PubMed PMID: 29968151]
[14] Tepper SJ, Anti-Calcitonin Gene-Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018. Headache. 2018 Nov;     [PubMed PMID: 30403405]
[15] Scott LJ, Rimegepant: First Approval. Drugs. 2020 May;     [PubMed PMID: 32270407]
[16] Scott LJ, Ubrogepant: First Approval. Drugs. 2020 Feb;     [PubMed PMID: 32020557]